A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

Elisabeth I. Heath, Melvin Gaskins, Henry C. Pitot, Roberto Pili, Winston Tan, Robert Marschke, Glenn Liu, David Hillman, Fazlul Sarkar, Shijie Sheng, Charles Erlichman, Percy Ivy

Research output: Contribution to journalReview article

49 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)138-141
Number of pages4
JournalClinical Prostate Cancer
Volume4
Issue number2
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

tanespimycin
Androgen Receptors
Interleukin-6
Prostatic Neoplasms
Hormones
SERPIN-B5

Keywords

  • Androgen receptor
  • Hsp90
  • Interleukin-6
  • Maspin

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. / Heath, Elisabeth I.; Gaskins, Melvin; Pitot, Henry C.; Pili, Roberto; Tan, Winston; Marschke, Robert; Liu, Glenn; Hillman, David; Sarkar, Fazlul; Sheng, Shijie; Erlichman, Charles; Ivy, Percy.

In: Clinical Prostate Cancer, Vol. 4, No. 2, 09.2005, p. 138-141.

Research output: Contribution to journalReview article

Heath, EI, Gaskins, M, Pitot, HC, Pili, R, Tan, W, Marschke, R, Liu, G, Hillman, D, Sarkar, F, Sheng, S, Erlichman, C & Ivy, P 2005, 'A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer', Clinical Prostate Cancer, vol. 4, no. 2, pp. 138-141.
Heath, Elisabeth I. ; Gaskins, Melvin ; Pitot, Henry C. ; Pili, Roberto ; Tan, Winston ; Marschke, Robert ; Liu, Glenn ; Hillman, David ; Sarkar, Fazlul ; Sheng, Shijie ; Erlichman, Charles ; Ivy, Percy. / A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer. In: Clinical Prostate Cancer. 2005 ; Vol. 4, No. 2. pp. 138-141.
@article{937e3654fc5e4b94958fba93bba43680,
title = "A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer",
keywords = "Androgen receptor, Hsp90, Interleukin-6, Maspin",
author = "Heath, {Elisabeth I.} and Melvin Gaskins and Pitot, {Henry C.} and Roberto Pili and Winston Tan and Robert Marschke and Glenn Liu and David Hillman and Fazlul Sarkar and Shijie Sheng and Charles Erlichman and Percy Ivy",
year = "2005",
month = "9",
language = "English (US)",
volume = "4",
pages = "138--141",
journal = "Clinical Genitourinary Cancer",
issn = "1558-7673",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - A phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

AU - Heath, Elisabeth I.

AU - Gaskins, Melvin

AU - Pitot, Henry C.

AU - Pili, Roberto

AU - Tan, Winston

AU - Marschke, Robert

AU - Liu, Glenn

AU - Hillman, David

AU - Sarkar, Fazlul

AU - Sheng, Shijie

AU - Erlichman, Charles

AU - Ivy, Percy

PY - 2005/9

Y1 - 2005/9

KW - Androgen receptor

KW - Hsp90

KW - Interleukin-6

KW - Maspin

UR - http://www.scopus.com/inward/record.url?scp=26944439006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944439006&partnerID=8YFLogxK

M3 - Review article

VL - 4

SP - 138

EP - 141

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 2

ER -